Biodel Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 39

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 12

  • Investments
  • 1

Biodel General Information

Description

Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules.

Contact Information

Website
www.biodel.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 100 Saw Mill Road
  • Danbury, CT 06810
  • United States
Primary Industry
Pharmaceuticals
Acquirer
Albireo
Corporate Office
  • 100 Saw Mill Road
  • Danbury, CT 06810
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biodel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biodel‘s full profile, request access.

Request a free trial

Biodel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of endocrine disorders treatments based in Danbury, Connecticut. The company develops its product candidates b
Pharmaceuticals
Danbury, CT
39 As of 2014
00000
000000 - 000

00000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
000000000000000
Rockville, MD
00 As of 0000
00000
000000000 00000

000000

t nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
000000000000000
Princeton, NJ
000 As of 0000
00000
000000000 00 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biodel Competitors (49)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kolon TissueGene Corporation Rockville, MD 00 00000 000000000 00000
Amicus Therapeutics Formerly VC-backed Princeton, NJ 000 00000 000000000 00 00000
Histogen Formerly VC-backed San Ramon, CA 0 00000 0000000000.
MetaboGen Formerly Accelerator/Incubator backed Stockholm, Sweden 0 00.000 00000000000
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 49 competitors. Get the full list »

Biodel Board Members (9)

Name Representing Role Since
0000000 0000000 00 Self Board Member 000 0000
000 000000000 00.0 Self Board Member 000 0000
00000 00000 Albireo Board Member 000 0000
You’re viewing 3 of 9 board members. Get the full list »

Biodel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biodel Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biodel‘s full profile, request access.

Request a free trial

Biodel Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Albireo 03-Nov-2016 0000000 00 000.00 Biotechnology
To view Biodel’s complete acquisitions history, request access »

Biodel FAQs

  • When was Biodel founded?

    Biodel was founded in 2003.

  • Who is the founder of Biodel?

    Solomon Steiner Ph.D, Erik Steiner, and Brian Pereira MD are the founders of Biodel.

  • Where is Biodel headquartered?

    Biodel is headquartered in Danbury, CT.

  • What is the size of Biodel?

    Biodel has 39 total employees.

  • What industry is Biodel in?

    Biodel’s primary industry is Pharmaceuticals.

  • Is Biodel a private or public company?

    Biodel is a Private company.

  • What is Biodel’s current revenue?

    The current revenue for Biodel is 00000.

  • How much funding has Biodel raised over time?

    Biodel has raised $223M.

  • Who are Biodel’s investors?

    Great Point Partners, Lancet Capital, Lincoln Park Capital, NMT Capital, and OrbiMed are 5 of 8 investors who have invested in Biodel.

  • Who are Biodel’s competitors?

    Kolon TissueGene, Amicus Therapeutics, Histogen, MetaboGen, and Pfizer Pakistan are some of the 49 competitors of Biodel.

  • Who acquired Biodel?

    Biodel was acquired by Albireo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »